Purchase Order HHSN272201700973P

Award Date 8/10/17
Potential Completion Date 8/31/17
Potential Value $51K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Auburn, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $14,577 firm-fixed-price purchase order is for the supply of microbeads and columns for the MACS cell separation system, which is used to support biomedical research and cell therapy development programs at the NIH Clinical Center. This award is part of a larger indefinite...
This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $4,566.00 firm fixed-price purchase order is for the delivery of an Isolation Kit and Isolation Beads, with a completion date of July 8, 2016. The contract is not designated as a set-aside award. Miltenyi Biotec is an experienced federal contractor, having previously...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,356 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of isolation kits. This award is not associated with a set-aside program. Miltenyi Biotec provides specialized instruments, reagents, and services to support biomedical research and cell therapy development. Through this contract, the company will supply the NIAID with the necessary products for...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $5,550.00, is for the delivery and installation of specialized laboratory equipment and related reagents and consumables. This includes flow cytometers, cell sorters, tissue dissociators, and automated cell separation systems, as well as proprietary reagents and...
This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, is a one-time maintenance purchase order valued at $3,425.00. The contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and did not have a set-aside designation. Miltenyi Biotec is an experienced federal contractor, having previously received awards from various agencies including the NIH, Department of Veterans Affairs,...
This federal contract award to Miltenyi Biotec, Inc. is for the delivery of dissociation kits, isolation kits, and columns. The $9,617.00 firm fixed price purchase order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The award is not associated with a set-aside program and the ultimate completion date was September 30, 2017. Miltenyi Biotec, a global biotechnology company, has extensive experience...
This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
This federal contract award, with an ID of HHSN272201100571P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract is for the supply of microbeads and columns for the AutoMACS automated cell separator, including shipping and handling, with a one-year period of performance from June 14, 2011, to June 13, 2012. The contract is a firm-fixed-price...
This federal contract award to Miltenyi Biotec, Inc. is a $5,400 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is not set aside and has an ultimate completion date of May 15, 2013. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical...
This federal contract award to Miltenyi Biotec, Inc. is for the supply of a CD1C (BDCA-1)+ Dendritic Cell Isolation Kit, a specialized reagent product used in biomedical research and cell therapy development. The $5,762 firm fixed price contract was awarded on December 20, 2012 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract does not have a set-aside designation. As a prime contractor, Miltenyi Biotec has...

This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $51,351.50 Firm Fixed Price contract is for the supply of CD4 and CD8 microbeads and cell isolation kits. The award was not made under any set-aside program.

The contract is likely part of a larger indefinite delivery contract (IDC) that Miltenyi Biotec holds with the NIH Clinical Center, valued at $2.3 million. This IDC, awarded in June 2023, provides for the supply of proprietary CliniMACS cell isolation reagents and consumables to support the NIH's cell therapy manufacturing and clinical trial programs through September 2024, with options to extend to 2027.

As a global biotechnology company, Miltenyi Biotec is an experienced federal contractor, having provided specialized laboratory equipment, reagents, and technical services to numerous government agencies including the NIH, VA, FDA, DoD, CDC, and USDA. The company's offerings focus on cell separation, analysis, and processing technologies that are critical for biomedical research and cell therapy development.

Generated 11/24/24, 9:29 AM